Sarepta Therapeutics (SRPT) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 22.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.51% |
| Dec 31, 2025 | 24.22% |
| Sep 30, 2025 | 25.63% |
| Jun 30, 2025 | 26.59% |
| Mar 31, 2025 | 24.41% |
| Dec 31, 2024 | 21.20% |
| Sep 30, 2024 | 15.35% |
| Jun 30, 2024 | 10.75% |
| Mar 31, 2024 | 7.07% |
| Dec 31, 2023 | 6.05% |
| Sep 30, 2023 | 7.34% |
| Jun 30, 2023 | 7.19% |
| Mar 31, 2023 | 10.02% |
| Dec 31, 2022 | 11.57% |
| Sep 30, 2022 | 14.83% |
| Jun 30, 2022 | 16.07% |
| Mar 31, 2022 | 20.78% |
| Dec 31, 2021 | 25.36% |
| Sep 30, 2021 | 37.38% |
| Jun 30, 2021 | 52.24% |
| Mar 31, 2021 | 55.59% |
| Dec 31, 2020 | 64.02% |
| Sep 30, 2020 | 64.08% |
| Jun 30, 2020 | 57.31% |
| Mar 31, 2020 | 52.91% |
| Dec 31, 2019 | 50.80% |
| Sep 30, 2019 | 49.71% |
| Jun 30, 2019 | 47.99% |
| Mar 31, 2019 | 42.17% |
| Dec 31, 2018 | 37.47% |
| Sep 30, 2018 | 27.15% |
| Jun 30, 2018 | 15.71% |
| Mar 31, 2018 | 12.61% |
| Dec 31, 2017 | 3.88% |
| Sep 30, 2017 | 1.50% |
| Jun 30, 2017 | 25.01% |
| Mar 31, 2017 | 24.03% |
| Dec 31, 2016 | 35.94% |
| Sep 30, 2016 | 62.87% |
| Jun 30, 2016 | 120.80% |
| Mar 31, 2016 | 128.79% |
| Dec 31, 2015 | 122.35% |
| Mar 31, 2015 | 109.52% |
| Dec 31, 2014 | 108.22% |
| Sep 30, 2014 | 147.74% |
| Jun 30, 2014 | 104.34% |
| Dec 31, 2013 | 93.72% |